Literature DB >> 12382992

Relearning face-name associations in early Alzheimer's disease.

Linda Clare1, Barbara A Wilson, Gina Carter, Ilona Roth, John R Hodges.   

Abstract

Preliminary evidence for the effectiveness of cognitive rehabilitation interventions based on errorless learning principles in early-stage Alzheimer's disease (AD) was provided by Clare et al. (1999, 2000, 2001). The present study extends these findings in a controlled trial. Twelve participants meeting criteria for probable AD, with Mini-Mental State Examination scores of 18 or above, were trained in face-name associations using an errorless learning paradigm. Training produced a significant group improvement in recall of trained, but not control, items. Gains were largely maintained 6 months later, in the absence of practice. There were differences in individual response to intervention. Results did not differ according to medication status, and the intervention had no adverse effects on self-reported well-being, but participants who were more aware of their memory difficulties achieved better outcomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382992     DOI: 10.1037//0894-4105.16.4.538

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  37 in total

1.  Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study.

Authors:  Henry W Mahncke; Bonnie B Connor; Jed Appelman; Omar N Ahsanuddin; Joseph L Hardy; Richard A Wood; Nicholas M Joyce; Tania Boniske; Sharona M Atkins; Michael M Merzenich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-03       Impact factor: 11.205

2.  Self-imagining enhances recognition memory in memory-impaired individuals with neurological damage.

Authors:  Matthew D Grilli; Elizabeth L Glisky
Journal:  Neuropsychology       Date:  2010-11       Impact factor: 3.295

3.  Face-name associative memory performance is related to amyloid burden in normal elderly.

Authors:  Dorene M Rentz; Rebecca E Amariglio; J Alex Becker; Meghan Frey; Lauren E Olson; Katherine Frishe; Jeremy Carmasin; Jacqueline E Maye; Keith A Johnson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2011-06-12       Impact factor: 3.139

4.  Comparing the effects of clinician and caregiver-administered lexical retrieval training for progressive anomia.

Authors:  Stephanie M Grasso; Kaleigh M Shuster; Maya L Henry
Journal:  Neuropsychol Rehabil       Date:  2017-06-30       Impact factor: 2.868

Review 5.  Cognitive reserve and its implications for rehabilitation and Alzheimer's disease.

Authors:  Giulia Liberati; Antonino Raffone; Marta Olivetti Belardinelli
Journal:  Cogn Process       Date:  2011-06-04

6.  A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease.

Authors:  L Tárraga; M Boada; G Modinos; A Espinosa; S Diego; A Morera; M Guitart; J Balcells; O L López; J T Becker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-04       Impact factor: 10.154

Review 7.  Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia.

Authors:  Alex Bahar-Fuchs; Linda Clare; Bob Woods
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 8.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

9.  Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of rats.

Authors:  E L Schaeffer; L Zorrón Pu; D A M Gagliotti; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

10.  Towards a cognitive stimulation program using an errorless learning paradigm in amnestic mild cognitive impairment.

Authors:  Léonie Jean; Martine Simard; Robert van Reekum; Marie-Eve Bergeron
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.